Journal of Molecular NeuroscienceGenetic & Genomic MedicinePeer-reviewed journal article
LncRNA PAN3-AS1 modulates cilium assemble signaling pathway through regulation of RPGR as a potential MS diagnostic biomarker: integrated systems biology investigation
Abstract
IntroductionMultiple sclerosis (MS), an autoimmune condition of the central nervous system (CNS), can lead to demyelination and axonal degeneration in the brain and spinal cord, which can cause progressive neurologic disability. MS symptoms include autonomic dysfunction, such as insomnia, neuropathic and nociceptive pain, cognitive impairment, spasticity, dysesthesia, anxiety, and depression, significantly reducing patient quality of life. These symptoms appear in addition to the progressive decline in the nervous systems motor abilities. In this investigation, we performed an integrated bioinformatics and experimental approach to find the expression level and interaction of a novel long non-coding RNA (lncRNA), PAN3-AS1, in MS samples. MethodsMicroarray analysis was performed by R Studio using GEOquery and limma packages. lncRNA-mRNA RNA interaction analysis was performed using the lncRRIsearch database. Pathway enrichment analysis was performed by KEGG and Reactome online software through the Enrichr database. Protein-protein interaction analysis was performed by STRING online software. Gene ontology (GO) analysis was performed by Enrichr database. ResultsBased on microarray analysis, lncRNA PAN3-AS1 has a significantly low expression in MS samples compared to the control (logFC: -1.2, adj. P. Val: 0.03). qRT-PCR results approved bioinformatics analyses. ROC analysis revealed that PAN3-AS1 could be considered a potential diagnostic biomarker of MS. Based on lncRNA-mRNA interaction analysis, lncRNA PAN3-AS1 regulates the expression level of RPGR. RPGR and its protein interactome regulate the cilium assembly, chaperon-mediated autophagy, and microarray biogenesis. ConclusionlncRNA PAN3-AS1, as a significant low-expressed lncRNA in MS samples, could be a potential diagnostic MS biomarker. PAN3-AS1 might regulate the expression level of cilium assembly and chaperon-mediated autophagy. Dysregulation of PAN3-AS1 might affect the expression of RPGR and its protein interactome.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 10th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Syndecan-1 as specific cerebrospinal fluid biomarker of multiple sclerosis
Geoffrey Hinsinger, Lucile Du Trieu de Terdonck, … Éric Thouvenot·bioRxiv·May 10, 2023
- Profiling of small non-coding RNAs across cellular and biofluid compartments: implications for multiple sclerosis immunopathology
Galina Yurevna Zheleznyakova, Eliane Piket, … Maja Jagodic·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 20, 2021
- Identification of hsa-miR-106a-5p as an impact agent on promotion of multiple sclerosis using multi-step data analysis.
Samira Rahimirad, Mohammad Navaderi, … Mohammad Hossein Sanati·Neurological SciencesPeer-reviewed·Jan 16, 2021
- Multiple Sclerosis Stages and their Differentially Expressed Genes: A Bioinformatics Analysis
Faten Alaya, Ghada Baraket, … Olaitan Igbagbo Awe·bioRxiv·Jan 20, 2024
- Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis
Basavaraj Mallikarjunayya Vastrad, Shivaling Pattanashetti, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Dec 5, 2023
- Akkermansia muciniphila-derived LPS links gut dysbiosis to pathogenic miR-21 signaling in experimental autoimmune encephalomyelitis.
Mallahalli S. Manu, Hirohiko Hohjoh, … Takashi Yamamura·bioRxiv·Jul 10, 2026